Insulin glulisine, human
Also sold as: insulin glulisine, human 100 UNT/ML Injectable Solution [Apidra], 3 ML insulin glulisine, human 100 UNT/ML Pen Injector [Apidra], insulin glulisine, human Pen Injector [Apidra], insulin glulisine, human Injectable Solution [Apidra]
Drug Equivalents
Different molecule, same mechanism of action or pharmacologic class (RxClass). These are therapeutic alternatives, not interchangeable without physician guidance.
Class: Insulin
- centruroides (scorpion) immune f(ab')2 (equine)AntidoteSame Class
- insulin detemirAntidoteSame Class
- fomepizoleAntidoteSame Class
- insulin degludecAntidoteSame Class
- acetylcysteineAntidoteSame Class
- prussian blue insolubleAntidoteSame Class
- insulin, regular, humanAntidoteSame Class
- insulin glargineAntidoteSame Class
- pralidoximeAntidoteSame Class
- levocarnitineAntidoteSame Class
- insulin aspart, humanAntidoteSame Class
- hydroxocobalaminAntidoteSame Class
- leucovorinAntidoteSame Class
- pyridoxineAntidoteSame Class
- vitamin k1AntidoteSame Class
Insurance Coverage User-Reported
No community coverage data yet for insulin glulisine, human.
Submit Coverage DataDrug Information
Medical Disclaimer: Information on this page is sourced from FDA-approved labeling data and is for educational reference only. It does not constitute medical advice. This information does not establish a provider-patient relationship. Always verify with current prescribing information and consult a licensed healthcare professional before any clinical decision. Read full disclaimer.
Data sourced from RxNorm (NLM/NIH), FDA Orange Book, OpenFDA, DailyMed. Last updated: 2026-03-02.